Back to Journals » Journal of Pain Research » Volume 19

Multi-Institutional Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of Manual Maintenance Therapy for Chronic Bothersome Neck Pain [Response to Letter]

Authors Yun JM, Kim JY, Lee SH, Lee YJ ORCID logo, Heo I, Shin WC ORCID logo, Cho JH, Seo BK ORCID logo, Ha IH ORCID logo

Received 25 March 2026

Accepted for publication 1 April 2026

Published 17 April 2026 Volume 2026:19 611921

DOI https://doi.org/10.2147/JPR.S611921



Jung Min Yun,1 Ju Yeon Kim,2 Sook-Hyun Lee,2 Yoon Jae Lee,2 In Heo,3 Woo-Chul Shin,4 Jae-Heung Cho,5 Byung-Kwan Seo,6 In-Hyuk Ha2

1Jaseng Hospital of Korean Medicine, Seoul, Republic of Korea; 2Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul, Republic of Korea; 3Department of Korean Medicine Rehabilitation, Pusan National University Korean Medicine Hospital, Yangsan, Kyungnam, 50612, Republic of Korea; 4Department of Korean Medicine Rehabilitation, Kyung Hee University Medical Center, Seoul, Republic of Korea; 5Department of Rehabilitation Medicine of Korean Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea; 6Department of Acupuncture & Moxibustion, College of Korean Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University, Seoul, Republic of Korea

Correspondence: In-Hyuk Ha, Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, 540, Gangnam-gu, Seoul, 06110, Republic of Korea, Tel +82-2-2222-2740, Fax +82-2-2222-2737, Email [email protected]


View the original paper by Dr Yun and colleagues

This is in response to the Letter to the Editor


Dear editor

We sincerely thank the authors of the letter for their careful reading of our article and thoughtful comments regarding our study design, “Multi-Institutional Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of Manual Maintenance Therapy for Chronic Bothersome Neck Pain.” We appreciate the opportunity to clarify several aspects of the study design. Their comments are valuable in improving the transparency and interpretability of our protocol.

We address each point in turn.

Clarification Regarding the Title and Identification of the Study as a Protocol

We appreciate this important point. Although the manuscript states within the text that it is a study protocol, we acknowledge that the original title may not have sufficiently distinguished it from a randomized controlled trial. To improve clarity, we are willing to revise the title to explicitly indicate that this article is a study protocol.

Concern Regarding the Open-Label Design and Risk of Bias

We acknowledge that participant and clinician blinding was not feasible in this trial because of the nature of the intervention, making full blinding impractical. For this reason, the study was designed with blinded outcome assessment to reduce detection bias. We also recognize that subjective outcomes such as pain intensity may be susceptible to expectation and performance bias. Because this study was conceived as a pragmatic trial intended to reflect real-world clinical practice, additional blinding itself was not feasible; however, we agree that this point should be described more clearly in the Discussion section as study limitation.

Difference in Treatment Exposure Between Groups

We appreciate the concern regarding the difference in treatment frequency between the two groups. We agree that the unequal treatment exposure may introduce attention-related or dose-related effects. However, the purpose of this pragmatic trial was to evaluate the effectiveness of a strategy involving intermittent maintenance therapy, compared with a usual-care context with limited ongoing medical intervention, rather than the specific efficacy of manual therapy under tightly controlled explanatory conditions.

Use of Concomitant Treatments During the Study Period

We agree that concomitant treatments may act as potential confounders. However, in this pragmatic study, we planned to prospectively document all the additional treatments and support appropriate interpretation of the findings and also examine differences in overall healthcare utilization between the two groups. Nevertheless, we acknowledge that unrestricted co-interventions may influence the outcomes independently of the assigned intervention, and we are ready to clarify in the manuscript that the allowance of concomitant care was an intentional pragmatic design choice aimed at preserving real-world applicability, while also acknowledging its implications for internal validity.

Operational Definition of Recurrence Using NRS≥6

We appreciate this thoughtful comment regarding the definition of recurrence. The choice of NRS threshold was an operational definition based on the assumption that moderate-level pain may lead patients to seek additional medical services, particularly in the absence of a universally accepted standard definition of recurrence. We also acknowledge that any dichotomous cutoff may carry a risk of misclassification, particularly for values near the threshold. Therefore, we additionally specified the duration of pain as “over 2 weeks” so that recurrence would reflect only pain of sufficient severity that persisted for a clinically meaningful period of time.

In conclusion, we are grateful to the authors of the letter for raising these important points. Their comments have helped us identify aspects of the manuscript that would benefit from clearer explanation. We believe that addressing these issues will improve the transparency and readability of the manuscript.

Disclosure

The authors declare that they have no competing interests for this communication.

Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.